Clinical trials
REM Sleep Behavior Disorder trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
| Completed | 6 |
| Unknown status | 5 |
| Recruiting | 5 |
| Terminated | 5 |
| Enrolling by invitation | 4 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cedars-Sinai Medical Center | 3 |
| Mayo Clinic | 3 |
| Axovant Sciences Ltd. | 2 |
| CND Life Sciences | 2 |
| NYU Langone Health | 2 |
| University of Minnesota | 2 |
| Washington University School of Medicine | 2 |
| Yale University | 2 |
| Brigham and Women's Hospital | 1 |
| Czech Technical University in Prague | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| REM Sleep Behavior Disorder | 35 |
| Parkinson Disease | 18 |
| Lewy Body Disease | 9 |
| Multiple System Atrophy | 5 |
| Parkinson Disease, Secondary | 4 |
| Parkinsonian Disorders | 4 |
| Cognitive Dysfunction | 2 |
| Dementia | 2 |
| Nerve Degeneration | 2 |
| Primary Dysautonomias | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.